Page 9 - மலை பள்ளத்தாக்கு ம்ட் ஹோல்டிங்ஸ் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin News provided by Share this article  Mountain Valley MD Holdings Inc. (the Company or MVMD ) (CSE: MVMD) (FRA: 20MP) is pleased to announce that it has filed for an accelerated review of its macrocyclic lactone solubilization patent with the United States Patent and Trademark Office ( USPTO ). To support the accelerated patent examination request, the Company has provided the USPTO with new formulation analyses of different diluted concentrations of its Quicksol™ Ivermectin in solution, data that the company had fast-tracked for completion and validation by a third-party CRO. The Company previously confirmed its ability to make the anti-parasitic drug Ivermectin highly water-soluble without the use of organic solvents, improving its water solubility by nearly 5,000 times and that it had completed its initial safety and improved efficacy in pre-clinical validation with a leading t

United statesBritish columbiaMike farberDennis hancockMelissa diaz musaTrademark officeHealth servicesLife sciences at mountain valleyMountain valley md holdings incMinistry of healthCritical care allianceDrug administrationUnited states patentLife sciencesMountain valleyFront line